Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dabomb Protein BiotechROCO:6578 -0.61%58 Days Inventory is 32.51 as of Dec. 2025, which is 8% below its 10-year median of 35.53. GuruFocus rates ROCO:6578 with a GF Score™ of 58/100 and a GF Value™ of NT$14.48 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 1,873 Consumer Packaged Goods companies, Dabomb Protein Biotech ranks better than 84.78% on this metric.
The historical rank and industry rank for Dabomb Protein Biotech's Days Inventory or its related term are showing as below:
ROCO:6578'
s Days Inventory Range Over the Past 10 Years
Min: 16.1 Med: 35.53 Max: 40.34
Current: 37.96
During the past 13 years, Dabomb Protein Biotech's highest Days Inventory was 40.34. The lowest was 16.10. And the median was 35.53.
ROCO:6578's Days Inventory is ranked better than 84.78% of 1873
companies
in the Consumer Packaged Goods industry
Industry Median: 83.04
vs ROCO:6578: 37.96
Dabomb Protein Biotech's Days Inventory
declined
from Dec. 2024 (44.67) to Dec. 2025 (32.51).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Dabomb Protein Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 was 2.81.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dabomb Protein Biotech's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.27.
Dabomb Protein Biotech (ROCO:6578) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Dabomb Protein Biotech's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dabomb Protein Biotech's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Dabomb Protein Biotech Days Inventory Related Terms
Dabomb Protein Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Dabomb Protein Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Dabomb Protein Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dabomb Protein Biotech Days Inventory vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Dabomb Protein Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dabomb Protein Biotech (ROCO:6578) has a Days Inventory of 32.51 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dabomb Protein Biotech and its competitors. This is near median its historical median of 35.53. Over the past decade, Dabomb Protein Biotech's Days Inventory has ranged from 16.10 to 40.34. According to the industry distribution chart, Dabomb Protein Biotech ranks #285 out of 1873 companies in the Consumer Packaged Goods industry, placing it in the top 15.2%.
Is Dabomb Protein Biotech's Days Inventory too high?
Dabomb Protein Biotech's current Days Inventory of 32.51 is near median its 10-year median of 35.53. Over the past 10 years, this metric has ranged from a low of 16.10 to a high of 40.34. The Consumer Packaged Goods industry median Days Inventory is 83.04. Dabomb Protein Biotech's value of 32.51 is 60.9% below this industry median. Based on the distribution chart, Dabomb Protein Biotech ranks #285 out of 1873 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Dabomb Protein Biotech has a GF Score™ of 58/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's Days Inventory compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Dabomb Protein Biotech ranks #285 out of 1873 companies for Days Inventory. This places Dabomb Protein Biotech in the top 15% of its industry — outperforming the majority of peers. The industry median Days Inventory is 83.04. Dabomb Protein Biotech's value of 32.51 is 60.9% below this benchmark. Historically, Dabomb Protein Biotech's own Days Inventory has ranged from 16.10 to 40.34 over the past decade. While the company's 10-year median is 35.53 vs. the industry median of 83.04, Dabomb Protein Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Consumer Packaged Goods company?
The median Days Inventory among Consumer Packaged Goods companies is 83.04, based on 1,873 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dabomb Protein Biotech's current Days Inventory of 32.51 is 60.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dabomb Protein Biotech and its competitors. For the Consumer Packaged Goods industry, the median Days Inventory is 83.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dabomb Protein Biotech's current Days Inventory is 32.51, which is near median its own 10-year median of 35.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$14.48, compared to a current price of NT$16.35 — trading 12.9% above its estimated fair value. The current Days Inventory is 32.51, which is near median its 10-year median of 35.53 and 60.9% below the Consumer Packaged Goods industry median of 83.04. Dabomb Protein Biotech's overall GF Score™ is 58/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current Days Inventory is 32.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?
Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be overvalued.
The current stock price of NT$16.35 is trading 12.9% above its estimated GF Value™ of NT$14.48.
GuruFocus considers Dabomb Protein Biotech to be Modestly Overvalued.
Key valuation signals for ROCO:6578:
Days Inventory: 32.51 (near median its 10-year median of 35.53)
GF Value™: NT$14.48 vs. price of NT$16.35 (12.9% above fair value)
Industry Position: 60.9% below the Consumer Packaged Goods median (#285 of 1873)
No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
58GF Score
Get the complete analysis for ROCO:6578
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6578 has been successfully added to your 
